Dr. Ian Evetts

Ian has 20 years of experience in the pharmaceutical industry, gained through senior positions
in sales, marketing, business development & licensing in both multinational companies and biotech.

Most recently he was Evaluations Director for AstraZeneca, responsible for techno-commercial asset evaluation of in-house and externalisation opportunities on behalf of the ex-US Business.

With his extensive experience and knowledge in clinical practice and commercialisation of medicine, Ian works to shape and develop our pharma clients through critical inflection points, taking them to a successful fundraising. He is a consultant to research institutions, emerging biotechs and pharma companies for business development, asset valuation & commercialisation strategies.

Copyright 2016 Epiphany Capital